​
​

Verona Pharma (VRNA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Verona Pharma Revenue Highlights

0

Latest Revenue (Q)

$5.62M

Verona Pharma Revenue by Period

Verona Pharma Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$458.00K-98.86%
2021-12-31$40.00M100.00%
2020-12-31--100.00%
2019-12-31$2.35K-15.52%
2018-12-31$2.78K-99.85%
2017-12-31$1.84M100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31-100.00%
2005-12-31--

Verona Pharma generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Verona Pharma Revenue by Quarter

DateRevenueChange
2024-09-30$5.62M100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$940.06K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$458.00K100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$40.00M100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--100.00%
2019-12-31$2.35K100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--100.00%
2018-12-31$2.78K100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$1.84M100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2005-06-30--

Verona Pharma generated $5.62M in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Verona Pharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
APLSApellis Pharmaceuticals$366.28M$176.57M
PTGXProtagonist Therapeutics$60.00M$4.67M
IDYAIDEAYA Biosciences$23.39M-
MREOMereo BioPharma Group$10.00M-
XFORX4 Pharmaceuticals-$560.00K
VKTXViking Therapeutics--
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
VRNAVerona Pharma-$5.62M
MDGLMadrigal Pharmaceuticals-$62.17M
SNDXSyndax Pharmaceuticals-$12.50M
TERNTerns Pharmaceuticals--
VTYXVentyx Biosciences--
AKROAkero Therapeutics--
MLTXMoonLake Immunotherapeutics--

VRNA Revenue FAQ

What is Verona Pharma’s yearly revenue?

Verona Pharma's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $458K, representing a decrease of -98.86% compared to 2021. VRNA's yearly revenue for 2021 was $40M, representing an increase of 100.00% compared to 2020.

What is Verona Pharma’s quarterly revenue?

Verona Pharma's quarterly revenue for Q3 2024 was $5.62M, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). VRNA's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Verona Pharma’s revenue growth rate?

Verona Pharma's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.